Factors to Consider When Selecting Next-Generation Sequencing (NGS) Technology

Jul 29, 2021 2:00:00 PM / by Champions Oncology posted in NGS

Next-generation sequencing (NGS) technology has transformed the biomedical research landscape. Only a few years ago, high resolution genome or exome sequencing would be cumbersome and cost-restrictive, but current NGS technology platforms now allow for basic and clinical researchers to include these approaches for routine DNA and RNA sequencing needs. What are the different NGS sequencing approaches and how are they applied to oncology research?

Read More →

Preclinical Oncology NGS Applications

Jun 17, 2021 11:00:00 AM / by Champions Oncology posted in NGS

Advances in preclinical oncology research are dependent on gaining insights into tumor biology and applying these insights to the development of novel diagnostics or therapeutics. Next-generation sequencing (NGS) technology has been instrumental in bridging basic immuno-oncology findings and preclinical applications. Here we provide an overview of NGS applications that are transforming preclinical oncology research.

Read More →

Next Generation Sequencing: Revolutionizing Oncology Research One Base-Pair at a Time

Apr 1, 2021 10:45:00 AM / by Champions Oncology posted in NGS

Advances in oncology research have led to the development of personalized treatments based on specific knowledge of a patient’s tumor. New therapies have been customized to target signaling pathways that are hyperactivated or block specific variants of cell surface molecules, thus leading to better anti-tumor responses. Next generation sequencing (NGS) technology has been at the forefront of these breakthroughs by enabling researchers to rapidly sequence RNA transcripts (RNA-seq) or exons (whole exome sequencing; WES) within tumor tissue and translate these findings into novel therapies.

Read More →
Content not found